When Every Hour Counts: How Cryoport Systems Rapidly Mobilized To Protect INmune Bio's Critical Clinical Materials

In the fast-paced world of advanced cell and gene therapy development, even the most meticulously planned clinical programs can be disrupted by the unexpected. INmune Bio, a clinical-stage biotech company focused on immunotherapies for cancer, faced such a moment when a biostorage facility suddenly shut down, putting critical clinical trial materials and patient timelines at risk. The incident exposed the fragility of clinical infrastructure. It emphasized the essential role of logistics, BioServices, and real-time coordination in safeguarding therapeutic progress and operational elements that can make or break clinical continuity.

What unfolded next was not just a story of technical recovery, but a demonstration of how cross-functional collaboration and longstanding partnerships can prevent potential clinical disasters. With less than 24 hours’ notice, Cryoport Systems mobilized its global team, rescued six high-stakes shipments, and ensured INmune Bio’s program stayed on track. Examine how to secure and save your future trial materials in the event of a crisis.